These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1904495)

  • 1. Probenecid enhances central nervous system uptake of 2',3'-dideoxyinosine by inhibiting cerebrospinal fluid efflux.
    Galinsky RE; Flaharty KK; Hoesterey BL; Anderson BD
    J Pharmacol Exp Ther; 1991 Jun; 257(3):972-8. PubMed ID: 1904495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies.
    Anderson BD; Hoesterey BL; Baker DC; Galinsky RE
    J Pharmacol Exp Ther; 1990 Apr; 253(1):113-8. PubMed ID: 2109797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose dependence in the plasma pharmacokinetics and uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats.
    Hoesterey BL; Galinsky RE; Anderson BD
    Drug Metab Dispos; 1991; 19(5):907-12. PubMed ID: 1686234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of probenecid on brain-cerebrospinal fluid-blood distribution kinetics of E-Delta 2-valproic acid in rabbits.
    Scism JL; Powers KM; Artru AA; Chambers AC; Lewis L; Adkison KK; Kalhorn TF; Shen DD
    Drug Metab Dispos; 1997 Dec; 25(12):1337-46. PubMed ID: 9394022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.
    Takasawa K; Terasaki T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Apr; 281(1):369-75. PubMed ID: 9103519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration.
    Wong SL; Hedaya MA; Sawchuk RJ
    Pharm Res; 1992 Feb; 9(2):228-35. PubMed ID: 1553347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine transport within the rabbit brain during intracerebroventricular administration and the effect of probenecid.
    Wang Y; Wei Y; Sawchuk RJ
    J Pharm Sci; 1997 Dec; 86(12):1484-90. PubMed ID: 9423165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.
    Takasawa K; Terasaki T; Suzuki H; Ooie T; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1509-17. PubMed ID: 9316866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the enhanced uptake of zidovudine (AZT) into cerebrospinal fluid. 1. Effect of probenecid.
    Sawchuk RJ; Hedaya MA
    Pharm Res; 1990 Apr; 7(4):332-8. PubMed ID: 2362907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of vascular contrast media into brain tissue and cerebrospinal fluid. An experimental study in rats.
    Harnish PP; Mukherji M
    Invest Radiol; 1989 Jun; 24(6):463-6. PubMed ID: 2521128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of brain tissue localized purine metabolizing enzymes in the central nervous system delivery of anti-HIV agents 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
    Singhal D; Morgan ME; Anderson BD
    Pharm Res; 1997 Jun; 14(6):786-92. PubMed ID: 9210198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.
    Salzer W; Widemann B; McCully C; Adamson PC; Balis FM
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):235-40. PubMed ID: 11592346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system targeting of 2',3'-dideoxyinosine via adenosine deaminase-activated 6-halo-dideoxypurine prodrugs.
    Morgan ME; Chi SC; Murakami K; Mitsuya H; Anderson BD
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2156-65. PubMed ID: 1444295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina.
    Tuntland T; Ravasco RJ; al-Habet S; Unadkat JD
    Pharm Res; 1994 Feb; 11(2):312-7. PubMed ID: 8165194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.
    Klecker RW; Jamis-Dow CA; Egorin MJ; Erkmen K; Parker RJ; Stevens R; Collins JM
    Drug Metab Dispos; 1994; 22(2):254-8. PubMed ID: 7912177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral efficacy, intracellular uptake and pharmacokinetics of free and liposome-encapsulated 2',3'-dideoxyinosine.
    Désormeaux A; Harvie P; Perron S; Makabi-Panzu B; Beauchamp D; Tremblay M; Poulin L; Bergeron MG
    AIDS; 1994 Nov; 8(11):1545-53. PubMed ID: 7848591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit.
    Hedaya MA; Sawchuk RJ
    J Pharm Sci; 1989 Sep; 78(9):716-22. PubMed ID: 2585262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
    Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats.
    Bramer SL; Au JL; Wientjes MG
    J Pharmacol Exp Ther; 1993 May; 265(2):731-8. PubMed ID: 8496819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the neuroprotective glutamate antagonist NBQX (6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione) in mice, rats, and dogs. Interactions with probenecid.
    Dalgaard L; Hjortkjaer RK; Regnier B; Nordholm L
    Drug Metab Dispos; 1994; 22(2):289-93. PubMed ID: 7912178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.